Alyeska Investment Group
PASG icon

Alyeska Investment Group’s Passage Bio PASG Stock Holding History

Alyeska Investment Group’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,000
Closed -$236K – 456
2022
Q2 		$236K Buy
+5,000
New +$234K ﹤0.01% 547
2021
Q4 		– Sell
-6,940
Closed -$1.38M – 702
2021
Q3 		$1.38M Sell
6,940
-10,000
-59% -$2.38M 0.02% 560
2021
Q2 		$4.49M Hold
16,940
– – 0.05% 372
2021
Q1 		$5.92M Buy
16,940
+2,545
+18% +$1.09M 0.08% 300
2020
Q4 		$7.36M Sell
14,395
-115
-0.8% -$46K 0.1% 228
2020
Q3 		$3.81M Hold
14,510
– – 0.06% 290
2020
Q2 		$7.93M Sell
14,510
-5,898
-29% -$2.65M 0.12% 224
2020
Q1 		$6.43M Buy
+20,408
New +$6.38M 0.13% 166

Other funds holding PASG

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Alyeska Investment Group's PASG Position: Q3 2022 in Review

Alyeska Investment Group sold out of Passage Bio (PASG) in Q3 2022, closing a stake of 5,000 shares — an estimated $236K sold.

Alyeska Investment Group first reported a position in PASG in Q1 2020 and held it in 8 quarters. The position peaked at $7.93M in Q2 2020. 75 funds tracked by Wall St. Rank hold PASG as of Q3 2022.

  • Alyeska Investment Group reported no remaining Passage Bio position as of Q3 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 5,000 Passage Bio shares in Q3 2022, an estimated $236K.
  • Alyeska Investment Group first reported a position in Passage Bio in Q1 2020 and held it in 8 quarters.
  • Alyeska Investment Group's Passage Bio position peaked at $7.93M in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Passage Bio as of Q3 2022.

Based on Alyeska Investment Group's 13F filing for Q3 2022, filed 14 Nov 2022.